Glucocorticoid-induced osteoporosis

被引:47
|
作者
Reid, IR [1 ]
机构
[1] Univ Auckland, Dept Med, Auckland, New Zealand
关键词
corticosteroid; prednisone; prednisolone; Cushing's syndrome; fracture; bone density; bisphosphonates; vitamin D; calcitonin; fluoride;
D O I
10.1053/beem.2000.0074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoid drugs interact with bone metabolism at many levels, but their principal action is to reduce osteoblast number and bone matrix synthesis. Virtually all patients receiving glucocorticoids in doses above 5 mg per day lose bone, the amount lost being dependent on the cumulative steroid dose. The risk of fracture is also related to the individual's initial bone density, which in turn reflects race, sex, age, menopausal status, body weight, smoking and the nature of any underlying illness. Bone density measurement and personal fracture history are the best predictors of future fracture risk. Steroid-induced bone loss is reversible, so measures to minimize the systemic steroid dose or to withdraw these drugs altogether should be pursued no matter how long an individual has been using them. Increasing the calcium intake to 1.5 g per day, encouraging them to stop smoking and take more exercise, and treating any vitamin D deficiency are sensible measures in all patients. In those at high risk, bisphosphonates are the best documented interventions, although sex hormone replacement is also effective and can be used alone or in addition to bisphosphonates.
引用
收藏
页码:279 / 298
页数:20
相关论文
共 50 条
  • [1] Glucocorticoid-induced osteoporosis
    Manelli, F
    Giustina, A
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (03): : 79 - 85
  • [2] Glucocorticoid-Induced Osteoporosis
    Buckley, Lenore
    Humphrey, Mary B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (26): : 2547 - 2556
  • [3] Glucocorticoid-Induced Osteoporosis
    Humphrey, Mary B.
    Buckley, Lenore
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (14): : 1378 - 1379
  • [4] GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    GENNARI, C
    [J]. CLINICAL ENDOCRINOLOGY, 1994, 41 (03) : 273 - 274
  • [5] Glucocorticoid-induced osteoporosis
    Kumar, R
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (05): : 589 - 595
  • [6] GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    Buttgereit, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 45 - 45
  • [7] Glucocorticoid-induced osteoporosis
    Compston, J
    [J]. HORMONE RESEARCH, 2003, 60 : 77 - 79
  • [8] Glucocorticoid-induced Osteoporosis
    Lamersdorf, A.
    Siggelkow, H.
    [J]. OSTEOLOGIE, 2016, 25 (04) : 269 - 272
  • [9] GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    LUKERT, BP
    RAISZ, LG
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1994, 20 (03) : 629 - 650
  • [10] Glucocorticoid-induced osteoporosis
    Cortet, Bernard
    [J]. ANNALES D ENDOCRINOLOGIE, 2023, 84 (03) : 373